Literature DB >> 8774885

Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.

Z Luo1, G Tzivion, P J Belshaw, D Vavvas, M Marshall, J Avruch.   

Abstract

The c-Raf-1 proto-oncoprotein is a Ras-GTP-regulated protein kinase that associates in situ with 14-3-3 proteins, which are naturally dimeric. In COS cells, recombinant Raf is found in oligomeric assemblies. To examine whether induced oligomerization can alter Raf kinase activity, sequences encoding the FK506-binding protein FKBP12 were fused to the amino terminus of c-Raf-1, introducing a binding site for FK506. Oligomerization of recombinant FKBP-Raf in situ, induced by the addition of the dimeric FK506 derivative FK1012A, activated Raf kinase activity at least half as well as epidermal growth factor (EGF). As with EGF, activation of FKBP-Raf by FK1012A is entirely Ras-GTP dependent. Thus oligomerization of Raf per se promotes Raf activation through a Ras-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774885     DOI: 10.1038/383181a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

1.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.

Authors:  M Tanowitz; J Si; D H Yu; G S Feng; L Mei
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 3.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen.

Authors:  S D Liberles; S T Diver; D J Austin; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 5.  Control of plant cytokinesis by an NPK1-mediated mitogen-activated protein kinase cascade.

Authors:  Takashi Soyano; Masaki Ishikawa; Ryuichi Nishihama; Satoshi Araki; Mayumi Ito; Masaki Ito; Yasunori Machida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-06-29       Impact factor: 6.237

Review 6.  Signal control through Raf: in sickness and in health.

Authors:  Jihan K Osborne; Elma Zaganjor; Melanie H Cobb
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 7.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

8.  The importance of Raf dimerization in cell signaling.

Authors:  Alyson K Freeman; Daniel A Ritt; Deborah K Morrison
Journal:  Small GTPases       Date:  2013-08-28

Review 9.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 10.  Vemurafenib: the first drug approved for BRAF-mutant cancer.

Authors:  Gideon Bollag; James Tsai; Jiazhong Zhang; Chao Zhang; Prabha Ibrahim; Keith Nolop; Peter Hirth
Journal:  Nat Rev Drug Discov       Date:  2012-10-12       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.